Advanced search×

Invasive intraductal papillary mucinous neoplasm: predictors of survival and role of adjuvant therapy.

Olivier Turrini, Joshua A Waters, Thomas Schnelldorfer, Keith D Lillemoe, Constantin T Yiannoutsos, Michael B Farnell, Michael G Sarr, and C Max Schmidt

HPB (Oxford) 12(7):447-55 (2010) PMID 20815853

Adjuvant treatment for pancreatic adenocarcinoma has been shown to improve survival. An increasingly recognized 'subtype' of pancreatic adenocarcinoma is invasive intraductal papillary mucinous neoplasm (IPMN). It is unclear whether adjuvant treatment for invasive IPMN improves survival. This study aimed to determine the impact of adjuvant treatment in invasive IPMN.

DOI: 10.1111/j.1477-2574.2010.00196.x
Version: za2963e q8za8 q8zbf q8zcf q8zd9 q8ze5 q8zf4 q8zg5
View PDF

Similar articles you may find interesting…

  1. The birth of pancreatic surgery: a tribute to Friedrich Wilhelm Wandesleben.
    Thomas Schnelldorfer

    World J Surg 34(1):190-3 (2010) PMID 19806393

    Friedrich Wilhelm Wandesleben (1800-1868), a small-town German physician, performed surgical drainage of a traumatic pancreatic pseudocyst in November 1841. This operation should be acknowledged as the world's first reported operation on the human pancreas. The surgeon, the operation...
  2. Co-prescription of gastroprotective agents in patients taking non-selective NSAIDs or COX-2 selective inhibitors: analysis of prescriptions.
    L L Pasina, A A Nobili, ... C C Bulla

    Int J Clin Pharmacol Ther 48(11):735-43 (2010) PMID 20979932

    To evaluate the prevalence of co-prescription of GPAs (proton pump inhibitors - PPIs and H2-receptor antagonists) and non-selective NSAIDs or COXIBs in patients registered under the local health authority (LHA) of Bergamo, a city in the north of Italy. A drug utilization analysis was done using the...
  3. [Pulmonary embolism in cancer: clinical analysis of 60 cases].
    Guo G Li, Wei-Xuan WX Lu, and Chen C Wang

    Zhonghua Zhong Liu Za Zhi 31(7):550-3 (2009) PMID 19950707

    The primary cancers were from respiratory system (36.7%), digestive system (26.7%), urogenital system (10.0%), hematological system (8.3%) and nervous system (5.0%), respectively, especially from such organ as lung (30.0%), stomach (8.3%), pancreas (6.7%), liver (5.0%) and so on. 12 of 18 patients (...